After selecting the malignant cells in the samples (Figure S2, Supporting Information), the initial analysis focused on the expression levels of B7‐H3, IL‐13Rα2, Her2, and ST8SIA1 in different GBM samples. The gene discussed is IL13RA2; the disease is glioblastoma.